Non-serogroupable Neisseria meningitidis pneumonia in an immunocompetent patient with severe COVID-19 pneumonia: A case report
- PMID: 36505907
- PMCID: PMC9732397
- DOI: 10.1016/j.idcr.2022.e01656
Non-serogroupable Neisseria meningitidis pneumonia in an immunocompetent patient with severe COVID-19 pneumonia: A case report
Abstract
Background: Non-serogroupable Neisseria meningitidis (N. meningitidis), the most common type of N. meningitidis in asymptomatic carriers, rarely causes infections. Most reported cases of infection are in patients with immunodeficiency, primarily complement deficiencies.
Case presentation: A 54-year-old immunocompetent man was transferred to our hospital to treat severe coronavirus disease 2019 (COVID-19). The patient presented with cough producing a large amount of purulent sputum, which was considered an atypical presentation of COVID-19. Gram staining of the sputum revealed a large number of gram-negative diplococci phagocytosed by many neutrophils, and a diagnosis of bacterial pneumonia was established. The culture yielded non-serogroupable N. meningitidis, and the patient was diagnosed with non-serogroupable N. meningitidis pneumonia. Potential immunodeficiency was considered; however, testing including human immunodeficiency virus and complement factors showed no abnormalities.
Conclusions: We report herein a rare case of non-serogroupable N. meningitidis pneumonia that occurred in an immunocompetent patient during the course of severe COVID-19. We consider impaired T cell function attributable to COVID-19 and dexamethasone administration may have triggered a transient immunosuppressive state and led to non-serogroupable N. meningitidis pneumonia.
Keywords: Coronavirus disease 2019 (COVID-19); Immunocompetent; Meningococcal pneumonia; N. meningitidis; Non-capsulated; Non-serogroupable.
© 2022 The Authors.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Meningococcal pneumonia in Japan: A case report and literature review.J Infect Chemother. 2016 Dec;22(12):833-836. doi: 10.1016/j.jiac.2016.07.014. Epub 2016 Sep 1. J Infect Chemother. 2016. PMID: 27591787
-
Lipopolysaccharide structure and serum sensitivity of non-serogroupable Neisseria meningitidis.J Clin Lab Immunol. 1987 Sep;24(1):29-32. J Clin Lab Immunol. 1987. PMID: 3119854
-
Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis-Active Bacterial Core Surveillance Sites, 2011-2016.Open Forum Infect Dis. 2019 Apr 15;6(5):ofz190. doi: 10.1093/ofid/ofz190. eCollection 2019 May. Open Forum Infect Dis. 2019. PMID: 31123695 Free PMC article.
-
Pneumonia and empyema caused by penicillin-resistant Neisseria meningitidis: a case report and literature review.Pediatrics. 2006 May;117(5):e1061-6. doi: 10.1542/peds.2005-1994. Epub 2006 Apr 10. Pediatrics. 2006. PMID: 16606681 Review.
-
Meningococcal pneumonia: a review.Pneumonia (Nathan). 2019 Aug 25;11:3. doi: 10.1186/s41479-019-0062-0. eCollection 2019. Pneumonia (Nathan). 2019. PMID: 31463180 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report; 2019. 〈https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2019.pdf〉. [Accessed 16 October 2021].
-
- Fijen C.A., Kuijper E.J., Tjia H.G., Daha M.R., Dankert J. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis. 1994;18:780–784. - PubMed
Publication types
LinkOut - more resources
Full Text Sources